Anesthetists and other healthcare professionals should assess this extra risk when managing surgical patients using a drug like Ozempic or Zepbound, particularly if they have other health issues ...

The Food and Drug Administration approved Ozempic for treating patients with chronic kidney disease on Tuesday, marking the latest authorized use for Novo Nordisk’s popular drug known for ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with ...

In most cases, a doctor will: Confirm whether you need Ozempic for diabetes or weight management. Review your insurance or check if you qualify for any patient assistance programs to lower the ...

“According to key opinion leaders (KOLs) interviewed by GlobalData, Ozempic could be an excellent option for patients who are diabetic and obese. In addition, KOLs believe that Ozempic has the ...

A spokesperson for Novo Nordisk, the manufacturer of Ozempic and Wegovy, said patient safety is a top priority for the company. “Novo Nordisk, on its part, has conducted an analysis across ...

PATIENTS taking blockbuster diabetes and weight loss drugs are waking up with vision loss, researchers warn. Some reported terrifying changes to their vision mere days or weeks after taking the jabs.

Patients taking Ozempic and similar weight loss drugs are reporting cases of sudden vision loss, including temporary and even permanent blindness. While these claims have circulated on Reddit for ...

“Ozempic serves a relatively niche market for type 2 diabetes patients, but that’s not the reason it’s in shortage now. The surge in demand stems from people discovering its off-label ...

The new approval allows doctors to prescribe Ozempic specifically to lower the risk of kidney failure, dialysis and death from heart-related problems in these high-risk patients. "Over the last 20 ...

Whether Ozempic and other similar drugs present a new way of treating AUD will depend on larger trials in patients more heavily afflicted by the disorder, experts said, and potentially whether ...

This approval makes Ozempic the first GLP-1 treatment for patients with both conditions. Chronic kidney disease is common in people with diabetes. About one in three adults with diabetes have kidney ...